19 (PB007): The SRG Rat, an immunodeficient model for orthotopic glioblastoma, diffuse intrinsic pontine glioma (DIPG) PDX, and intracranial metastatic breast cancer PDX tumors
D. Begemann, N. Fulcher, E. Fenton, C. Dunn, D. Robertson, C. Scutchfield, T. Keener, A. Deweyert, A. Elsaleh, H. Xu, C. De Oliveira, J. Kelly, J.A. Ronald, R.G. Walton, S. Sampathi, V. Steffey, M.J. Schlosser, S. Schmid, M.O. Hebb, F. Noto
{"title":"19 (PB007): The SRG Rat, an immunodeficient model for orthotopic glioblastoma, diffuse intrinsic pontine glioma (DIPG) PDX, and intracranial metastatic breast cancer PDX tumors","authors":"D. Begemann, N. Fulcher, E. Fenton, C. Dunn, D. Robertson, C. Scutchfield, T. Keener, A. Deweyert, A. Elsaleh, H. Xu, C. De Oliveira, J. Kelly, J.A. Ronald, R.G. Walton, S. Sampathi, V. Steffey, M.J. Schlosser, S. Schmid, M.O. Hebb, F. Noto","doi":"10.1016/j.ejca.2024.114548","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"211 ","pages":"Article 114548"},"PeriodicalIF":7.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804924012395","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.